MX3296E - Procedimiento para la obtencion de derivados de prostaglandina - Google Patents
Procedimiento para la obtencion de derivados de prostaglandinaInfo
- Publication number
- MX3296E MX3296E MX000165U MX16576U MX3296E MX 3296 E MX3296 E MX 3296E MX 000165 U MX000165 U MX 000165U MX 16576 U MX16576 U MX 16576U MX 3296 E MX3296 E MX 3296E
- Authority
- MX
- Mexico
- Prior art keywords
- lactol
- alkyl
- inclusive
- carbon atoms
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- 150000005215 alkyl ethers Chemical class 0.000 abstract 2
- 230000029936 alkylation Effects 0.000 abstract 2
- 238000005804 alkylation reaction Methods 0.000 abstract 2
- 150000002084 enol ethers Chemical class 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 229910052731 fluorine Chemical group 0.000 abstract 2
- 239000011737 fluorine Chemical group 0.000 abstract 2
- IXQAQZFQKCKBMU-UHFFFAOYSA-N C1(=CC=CC=C1)[PH2](C1=CC=CC=C1)C1=CC=CC=C1.C(=O)(O)C=CC Chemical compound C1(=CC=CC=C1)[PH2](C1=CC=CC=C1)C1=CC=CC=C1.C(=O)(O)C=CC IXQAQZFQKCKBMU-UHFFFAOYSA-N 0.000 abstract 1
- KZQDKDRMSDVWEY-UHFFFAOYSA-N C1=CC=CC=C1[PH2](C=1C=CC=CC=1)C1=CC=CC=C1 Chemical compound C1=CC=CC=C1[PH2](C=1C=CC=CC=1)C1=CC=CC=C1 KZQDKDRMSDVWEY-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
La presente invención se refiere a un procedimiento para la obtención de derivados de prostaglandina, ópticamente activos, de la fórmula:(VER gacetA) o una forma racémica de ese compuesto y el enantiómero del mismo en donde M es (VER GACETA), en donde R2 es hidrógeno, metilo o etilo; en donde E es trans-CHCH- o -CH2CH2-; en donde R8 es hidrógeno y R9 es hidrógeno, metilo o flúor, con la condición de que ninguno de R8 y R9 es metilo cuando R2 es metilo o etilo; en donde -CtH2t- representa un enlace de valencia o alquileno de uno a 9 átomos de carbono, inclusive, con de uno a 6 átomos de carbono, inclusive, entre -CR8R9- y el anillo; en donde T es alquilo de uno a 4 átomos de carbono, inclusive, flúor, cloro, trifluometilo o -OR3 en donde R3 es alquilo de uno a 4 átomos de carbono inclusive; y en donde s es cero, uno, 2 ó 3, con la condición de que no más de 2T sean otro que no sea alquilo, que consiste de los pasos de (1) la alquilación Wittig de un gamma-lactol ópticamente activo de la fórmula: (VER GACETA) o una fórmula racémica del gamma-lactol y el enantiómero del mismo, en donde R13 es un grupo de bloqueo removible; en donde M2 es R2OR13 o R2OR13, en donde R2 y R13 son como se ha definido en lo que antecede; en donde indica la fijación de hidroxi al anillo en la configuración beta o alfa; y en donde R8, R9, CtH2t, E, s y T son como se ha definido en lo que antecede; con un alcoximetilentrifenilfosforano de la fórmula (C8H5)3PCHOR4, en donde R4 es alquilo de uno a 4 átomos de carbono, inclusive, a fin de producir un éter de enol; (2) la ciclización del producto de éter de enol del paso (1) en un éter de alquilo de -lactol seguido por hidrólisis del éter de alquilo de -lactol en el -lactol correspondiente; y (3) la alquilación de Wittig del producto de -lactol del paso 2 con un carboxipropilentrifenilfosforano de fórmula (C6H5)3PCH-(CH2)2-COOH.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/580,747 US4032561A (en) | 1975-05-27 | 1975-05-27 | 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1.sub.α compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX3296E true MX3296E (es) | 1980-08-27 |
Family
ID=24322391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX000165U MX3296E (es) | 1975-05-27 | 1976-04-12 | Procedimiento para la obtencion de derivados de prostaglandina |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US4032561A (es) |
| JP (1) | JPS51141861A (es) |
| BE (1) | BE842275A (es) |
| CH (2) | CH623569A5 (es) |
| DE (1) | DE2623139A1 (es) |
| FR (1) | FR2312236A1 (es) |
| GB (1) | GB1554021A (es) |
| MX (1) | MX3296E (es) |
| NL (1) | NL7605537A (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1516414A (en) * | 1975-08-22 | 1978-07-05 | Ici Ltd | Prostane derivatives |
| US4123463A (en) * | 1978-03-21 | 1978-10-31 | The Upjohn Company | 2-Decarboxy-2-alkylketone prostaglandins |
| IE51533B1 (en) * | 1980-08-28 | 1987-01-07 | Ici Ltd | Pharmaceutical compositions of fungicidal triazole derivatives |
| JP2001504122A (ja) | 1996-11-12 | 2001-03-27 | アルコン ラボラトリーズ，インコーポレイテッド | 眼圧降下剤としてのプロスタグランジン類のｃｉｓ―δ▲上４▼アナログ |
| JP5221134B2 (ja) * | 2004-09-07 | 2013-06-26 | バイオコンパティブルズ ユーケー リミテッド | 塞栓剤からの薬物送達 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE794516A (fr) * | 1972-01-26 | 1973-05-16 | Wisconsin Alumni Res Found | Nouvelles prostaglandines et leur procede de preparation |
| US4304907A (en) * | 1972-05-10 | 1981-12-08 | The Upjohn Company | Bicyclo lactone intermediates for prostaglandin analogs |
| NL7306461A (es) * | 1973-05-09 | 1974-11-12 | ||
| ES434590A1 (es) * | 1974-02-15 | 1977-04-01 | Hoechst Ag | Procedimiento para la preparacion de nuevos compuestos ana- logos de acidos prostanoicos. |
-
1975
- 1975-05-27 US US05/580,747 patent/US4032561A/en not_active Expired - Lifetime
-
1976
- 1976-04-12 MX MX000165U patent/MX3296E/es unknown
- 1976-05-10 JP JP51052280A patent/JPS51141861A/ja active Pending
- 1976-05-11 CH CH590476A patent/CH623569A5/de not_active IP Right Cessation
- 1976-05-17 GB GB20243/76A patent/GB1554021A/en not_active Expired
- 1976-05-22 DE DE19762623139 patent/DE2623139A1/de not_active Withdrawn
- 1976-05-24 NL NL7605537A patent/NL7605537A/xx not_active Application Discontinuation
- 1976-05-26 BE BE167380A patent/BE842275A/xx not_active IP Right Cessation
- 1976-05-26 FR FR7616031A patent/FR2312236A1/fr active Granted
- 1976-11-12 US US05/741,246 patent/US4065631A/en not_active Expired - Lifetime
- 1976-11-12 US US05/741,245 patent/US4065628A/en not_active Expired - Lifetime
- 1976-11-12 US US05/741,244 patent/US4065629A/en not_active Expired - Lifetime
-
1980
- 1980-03-21 CH CH224380A patent/CH624100A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BE842275A (fr) | 1976-11-26 |
| FR2312236A1 (fr) | 1976-12-24 |
| JPS51141861A (en) | 1976-12-07 |
| US4065629A (en) | 1977-12-27 |
| CH623569A5 (es) | 1981-06-15 |
| US4065628A (en) | 1977-12-27 |
| US4032561A (en) | 1977-06-28 |
| DE2623139A1 (de) | 1976-12-16 |
| CH624100A5 (es) | 1981-07-15 |
| FR2312236B1 (es) | 1979-10-12 |
| GB1554021A (en) | 1979-10-17 |
| AU1360476A (en) | 1977-11-10 |
| NL7605537A (nl) | 1976-11-30 |
| US4065631A (en) | 1977-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES423466A1 (es) | Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3-alquinilaminopropanos. | |
| MX3343E (es) | Procedimiento para preparar analogos de prostaglandinas | |
| ES436117A1 (es) | Procedimiento para la preparacion de nuevos compuestos ana- logos de acidos prostanoicos que no se presentan en la natu-raleza. | |
| ES434533A1 (es) | Un procedimiento para la preparacion de compuestos tetraci-clicos. | |
| MX3296E (es) | Procedimiento para la obtencion de derivados de prostaglandina | |
| ES418924A1 (es) | Procedimiento para la obtencion de 13, 14-dihidroprosta- glandinas. | |
| GB1033777A (en) | Bis-anilide derivatives | |
| ES527319A0 (es) | Un procedimiento para la preparacion de derivados de fenil-piperazina | |
| ES400452A1 (es) | Procedimiento para la obtencion de un medio para regular el crecimiento de las plantas a base de acidos 2-halogenoe- tano sulfinicos. | |
| ES446698A1 (es) | Procedimiento para la preparacion de nuevos derivados de bi-fenilo. | |
| ES399873A1 (es) | Procedimiento para la preparacion de nuevos i-fenoxi-2- idroxi-3-alcahilamino propanos recemicos u opticamenacti- vos. | |
| ES396175A1 (es) | Procedimiento para la preparacion de compuestos derivados de aminoetanol. | |
| ES379619A1 (es) | Procedimiento para la preparacion de aminoacidos. | |
| ES418575A1 (es) | Un procedimiento para preparar un compuesto seleccionado delgrupo de antimeros y mezclas recenicas de los mismos. | |
| ES442022A1 (es) | Procedimiento para la preparacion de derivados de propanol. | |
| ES394679A1 (es) | Procedimiento para la preparacion de esteres de acido 1,2, 3,6 - tetrahidro-4-piridilmetil-carboxilixo. | |
| GB1538037A (en) | Process for the preparation of prostaglandins | |
| ES428047A1 (es) | Un procedimiento para la preparacion de nuevos derivados de prostaglandina. | |
| ES288798A1 (es) | Procedimiento para la producción de olefinas | |
| ES439465A1 (es) | Procedimiento para la preparacion de nuevos compuestos ana- logos de acidos prostanoicos. | |
| FR1019552A (fr) | Procédé de préparation de sels d'acides gras de streptomycine | |
| ES364980A1 (es) | Un metodo para preparar nuevos derivados de adamantano. | |
| GB1412663A (en) | 2- 4-biphenylyl- tetrahydrofurans and pharmaceutical compositions containing them | |
| ES395036A2 (es) | Procedimiento para producir un compuesto opticamente acti- vo. | |
| GB839494A (en) | Production of methylenedioxyphenyl derivatives |